<DOC>
	<DOCNO>NCT01139307</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study study biomarkers sample patient Down syndrome acute megakaryoblastic leukemia .</brief_summary>
	<brief_title>Biomarkers Samples From Patients With Down Syndrome Acute Megakaryoblastic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Determine whether megakaryocyte differentiation agent comprise Rho kinase inhibitor JAK3 inhibitor lead proliferation arrest , polyploidization , terminal differentiation blast specimens patient Down syndrome acute megakaryoblastic leukemia . OUTLINE : Cryopreserved specimen culture treated vivo ( mouse ) vitro megakaryocytic differentiation agent comprise Rho kinase inhibitor JAK3 inhibitor .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Megakaryoblastic , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute megakaryoblastic leukemia Diagnosis Down syndrome Cryopreserved specimen available PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>adult acute megakaryoblastic leukemia ( M7 )</keyword>
	<keyword>childhood acute megakaryocytic leukemia ( M7 )</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>recurrent childhood acute myeloid leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>untreated childhood acute myeloid leukemia myeloid malignancy</keyword>
</DOC>